Exported since. prigot. r-ra d / int. reception for children Pak. 5g # 6

Release form

Powder for preparation of a solution for oral administration, 5 g in single-dose sachets (sachets) - 6 pcs each, together with instructions for use, are placed in a cardboard box.

Dosage form

white crystalline powder

Structure

Lactitol monohydrate - 5 g in a sachet, without excipients.

pharmachologic effect

In the large intestine, lactitol is broken down by the intestinal flora into low molecular weight organic acids, which leads to an increase in osmotic pressure in the large intestine, an increase in the volume of feces, their softening, facilitating bowel movements and normalizing bowel function. The laxative effect usually occurs within 24 hours after using the drug (delay is due to the passage of the drug through the gastrointestinal tract). At the beginning of the course of treatment, a delay in the laxative effect of the drug is possible, the effect may occur on the second or third day of its use.

In patients with hepatic encephalopathy or hepatic coma (or precoma), the effect is achieved due to the migration of ammonia from the blood to the large intestine (due to a decrease in pH, an increase in osmotic pressure in the intestinal lumen), removal of trapped ammonium ions and other nitrogen-containing toxic substances from the large intestine.

Lactitol inhibits proteolytic bacteria and increases the number of acidophilic bacteria.

Pharmacokinetics

Lactitol exerts its effect only in the large intestine, where it is completely absorbed after ingestion.

It is absorbed in minimal amounts unchanged (no more than 0.5 - 2% of the dose taken).

Side effects

At the beginning of treatment, you may feel abdominal discomfort, flatulence.

These phenomena, as a rule, disappear with continued use of the drug, as you adapt to it.

In the case of using higher doses for a long time in the treatment of hepatic encephalopathy in a patient, due to diarrhea, electrolyte imbalance may develop.

Selling features

Available without a prescription

Special conditions

Lactitol has a low calorie content (2 kcal / g), does not affect blood glucose levels and can be used in patients with diabetes mellitus.

Throughout the course of the drug use, an increased fluid intake is desirable.

The use of Exportal® does not affect psychomotor functions associated with driving a car or controlling machines and mechanisms.

Indications

Constipation, the need to regulate stool for medical purposes (bowel cleansing in preparation for endoscopic and X-ray examinations, surgical interventions on the rectum, anal sphincter and the area adjacent to it), intestinal dysbiosis.

Hepatic encephalopathy, hepatic precoma and coma, hyperammonemia.

Contraindications

Individual intolerance to lactitol, galactosemia, bowel obstruction, suspicion of organic damage to the gastrointestinal tract, abdominal pain and rectal bleeding of unknown origin.

Drug interactions

While taking Exportal® with enteric preparations of pH-dependent release, it should be borne in mind that lactitol lowers intestinal pH.

It is not recommended to use Exportal® within two hours after taking other medicines.

Dosage

Inside during meals, mixing with various drinks (water, tea, coffee, juices, etc.) or liquid food.

For constipation and dysbiosis.

The drug should be taken once, the entire daily dose at once, at one time.

Children 1-6 years old - 2.5 - 5 g (1/2 - 1 teaspoon of powder) per day.

Children 6 - 12 years old — 5 - 10 g (1 - 2 teaspoons of powder) per day.

Children 12-16 years old — 10-20 g (2-4 teaspoons of powder) per day.

Adults: 20 g (4 teaspoons of powder) per day.

The drug should induce stool once a day

after the onset of a stable laxative effect for several days using

Name ENG

EXPORTALE

Clinical and pharmacological group

Laxative with osmotic properties

ATX code

Lactitol

Dosage

5g

Structure

Lactitol monohydrate - 5 g in a sachet, without excipients.

Indications

constipation, intestinal dysbiosis

the need to regulate the stool for medical purposes (bowel cleansing in preparation for endoscopic and X-ray examinations, surgical interventions on the rectum, anal sphincter and the area adjacent to it)

hepatic encephalopathy, hepatic precoma and coma, hyperammonemia.

Contraindications

individual intolerance to lactitol

galactosemia

intestinal obstruction

suspicion of organic damage to the gastrointestinal tract

abdominal pain

rectal bleeding of unknown origin.

INN / Active ingredient

lactitol monohydrate

Storage conditions and periods

In a dry, dark place.

Expiration date: 5 years

Specifications

Category

Preparations for the gastrointestinal tract

,

Laxatives

Scope of the drug

Gastrointestinal tract

Release form

Filter package

Manufacturer country

Russia

Package quantity, pcs

6

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

PharmVILAR

The amount of the dosage form in the primary package

5 g

Primary packaging type

Sachet (sachet)

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Laxative

Anatomical and therapeutic characteristics

A06AD12 Lactitol

Dosage form

Powder for preparation of oral solution

Dosage (volume) of the substance in the preparation

lactitol monohydrate 5 g

Expiration date in days

1825

The target audience

Children

Package weight, g

2

Mode of application

:

Inside during meals, mixing with various drinks (water, tea, coffee, juices, etc.) or liquid food. < br> For constipation and dysbiosis. The drug should be taken once, the entire daily dose at once, at one time. < br> Children 1-6 years old - 2.5 - 5 g (1/2 - 1 teaspoon of powder) per day. < br> Children 6-12 years old —5 - 10 g (1 - 2 teaspoons of powder) per day. < br> Children 12 - 16 years old —10 - 20 g (2 - 4 teaspoons of powder) per day. < br> Adults: 20 g (4 teaspoons tablespoons of powder) per day. < br> The drug should cause a chair once a day after the onset of a stable laxative effect for several days of using the drug, its dose can be reduced. In some cases, half of the recommended daily dose is sufficient to obtain the desired effect. The minimum course of therapy,after which you should seek medical advice - 5 months. The use of the drug in children is recommended under the supervision of a physician. < br> When adjusting stool for medical purposes. On 20 g of the drug, diluted in 1 liter of water, take three times (at 12, 15 and 18 hours) on the eve of medical procedures. < br> With hepatic encephalopathy, hepatic precoma and coma, hyperammonemia. The dose of the drug should be selected individually for each patient, depending on the severity of the disease and the individual response to the drug. The initial daily dose is usually 0.5-0.7 g per 1 kg of body weight. This dose is divided into three single doses. It is taken with meals. The dose should be adjusted to produce two soft" stools per day. < br> The use of the drug in children is recommended under the supervision of a physician. < br> When adjusting the stool for medical purposes. On 20 g of the drug, diluted in 1 liter of water, take three times (at 12, 15 and 18 hours) on the eve of medical procedures. < br> With hepatic encephalopathy, hepatic precoma and coma, hyperammonemia. The dose of the drug should be selected individually for each patient, depending on the severity of the disease and the individual response to the drug. The initial daily dose is usually 0.5-0.7 g per 1 kg of body weight. This dose is divided into three single doses. It is taken with meals. The dose should be adjusted to produce two "soft" stools per day. < br> The use of the drug in children is recommended under the supervision of a physician. < br> When adjusting the stool for medical purposes. On 20 g of the drug, diluted in 1 liter of water, take three times (at 12, 15 and 18 hours) on the eve of medical procedures. < br> With hepatic encephalopathy, hepatic precoma and coma, hyperammonemia. The dose of the drug should be selected individually for each patient, depending on the severity of the disease and the individual response to the drug. The initial daily dose is usually 0.5-0.7 g per 1 kg of body weight. This dose is divided into three single doses. It is taken with meals. The dose should be adjusted to produce two "soft" stools per day. < br> take three times (at 12, 15 and 18 hours) on the eve of medical procedures. < br> With hepatic encephalopathy, hepatic precoma and coma, hyperammonemia. The dose of the drug should be selected individually for each patient, depending on the severity of the disease and the individual response to the drug. The initial daily dose is usually 0.5-0.7 g per 1 kg of body weight. This dose is divided into three single doses. It is taken with meals. The dose should be adjusted to produce two "soft" stools per day. < br> take three times (at 12, 15 and 18 hours) on the eve of medical procedures. < br> With hepatic encephalopathy, hepatic precoma and coma, hyperammonemia. The dose of the drug should be selected individually for each patient, depending on the severity of the disease and the individual response to the drug. The initial daily dose is usually 0.5-0.7 g per 1 kg of body weight. This dose is divided into three single doses. It is taken with meals. The dose should be adjusted to produce two "soft" stools per day. < br> The initial daily dose is usually 0.5-0.7 g per 1 kg of body weight. This dose is divided into three single doses. It is taken with meals. The dose should be adjusted to produce two "soft" stools per day. < br> The initial daily dose is usually 0.5-0.7 g per 1 kg of body weight. This dose is divided into three single doses. It is taken with meals. The dose should be adjusted to produce two "soft" stools per day. < br>

Information on technical characteristics, delivery set, country of manufacture "